Russell Frank Company’s Halozyme HALO Stock Holding History

Russell Frank Company’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-32,810	Closed	-$741K	–	3016
2015 Q2	$741K	Sell	32,810 -23,119	-41%	-$406K	﹤0.01%	2449
2015 Q1	$799K	Buy	+55,929	New	+$806K	﹤0.01%	2249
2013 Q4	–	Sell	-8,118	Closed	-$92K	–	2900
2013 Q3	$92K	Sell	8,118 -86	-1%	-$717	﹤0.01%	2976
2013 Q2	$53K	Buy	+8,204	New	+$52.3K	﹤0.01%	2858

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's HALO Position: Q3 2015 in Review

Russell Frank Company sold out of Halozyme (HALO) in Q3 2015, closing a stake of 32,810 shares — an estimated $741K sold.

Russell Frank Company first reported a position in HALO in Q2 2013 and held it in 4 quarters. The position peaked at $799K in Q1 2015. 175 funds tracked by Wall St. Rank hold HALO as of Q3 2015.

Russell Frank Company reported no remaining Halozyme position as of Q3 2015 after selling out during the quarter.
Russell Frank Company sold 32,810 Halozyme shares in Q3 2015, an estimated $741K.
Russell Frank Company first reported a position in Halozyme in Q2 2013 and held it in 4 quarters.
Russell Frank Company's Halozyme position peaked at $799K in Q1 2015.
175 funds tracked by Wall St. Rank held Halozyme as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.